Intellectual Property - July 24, 2018
US patent granted for Spago Nanomedical
Spago Nanomedical announce that the United States Patent and Trademark Office (USPTO) has granted the company´s patent application comprising product protection for Tumorad in the USA. Tumorad is based on nanoparticles loaded with a radioisotope and holds potential to become a new treatment of solid tumors. Earlier this year the USPTO issued a preliminary approval […]
Intellectual Property - May 14, 2018
New results from Follicum
The company’s diabetes project is progressing as planned and the company has submitted an enhanced patent application for its novel peptide drug candidate class. A large amount of results have been processed to complete the application submitted in early May 2017. The results show that the new peptide class has the potential to become a […]
Intellectual Property - May 3, 2018
US patent granted for Moberg Pharma
The United States Patent and Trademark Office (USPTO) has issued Patent No. US 9,956,211 which protects BUPI, currently in development for pain due to oral mucositis. This patent should provide protection through to 2032. The U.S. patent covers a method for the treatment of pain due to oral mucositis in cancer patients by locally administering […]
Intellectual Property - March 8, 2018
Additional patent approval for Oncopeptides
Oncopeptides announces that the Japanese Patent Office (JPO) recently issued a notice that they will grant an additional Japanese patent to Oncoeptides. The patent (application JP 2015-539556) covers inter alia the lyophilized formulation of Ygalo that is intended to be launched. The patent will expire in October 2033. “We are pleased to have received this […]
Intellectual Property - February 28, 2018
Athera receives patent approval
Athera Biotechnologies announces that a composition of matter patent covering antibodies with binding to phosphorylcholine, PC has been allowed by the European Patent Office, EPO. The PC target is part of modified phospholipids and has been characterized as an active driver of vascular inflammation. The therapeutic antibodies covered by the patent are designed to target […]
Intellectual Property - February 5, 2018
BioArctic receives US patent
The US Patent and Trademark Office (USPTO) published an Issue of Notification of granting the company’s patent application for a method with the medical device, which is one of the components in the product candidate SC0806. The notification states that the US patent will be granted and enters into force on February 20, 2018. The patent […]
